NorthWest Biotherapeutics Inc (NWBO)

[barcode27]

I'm interested to hear more about what you see in the way of patents that Cognate holds. I'm not seeing many. In fact, I see one:

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&p=1&f=G&l=50&d=PTXT&S1=(cognate.ASNM.+AND+bioservices.ASNM.)&OS=an/cognate+and+an/bioservices&RS=(AN/cognate+AND+AN/bioservices)

PAT. NO. Title
9,255,249 Full-Text Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates




This is compared to what NWBO is listed as the assignee on:

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&p=1&f=S&l=50&Query=an%2Fnorthwest+and+an%2Fbiotherapeutics&d=PTXT

PAT. NO. Title
1 9,566,294 Full-Text Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
2 9,102,917 Full-Text Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
3 8,518,636 Full-Text Tangential flow filtration devices and methods for leukocyte enrichment
4 8,409,566 Full-Text Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
5 8,389,278 Full-Text Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
6 7,790,039 Full-Text Tangential flow filtration devices and methods for stem cell enrichment
7 7,695,627 Full-Text Tangential flow filtration devices and methods for leukocyte enrichment
8 7,087,715 Full-Text Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
9 6,936,448 Full-Text Nucleic acids and proteins of a rat ganglioside GM1-specific .alpha.1-2fucosyltransferase and uses thereof
10 6,863,887 Full-Text Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
11 6,150,508 Full-Text Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
12 5,990,294 Full-Text Nucleotide and amino acid sequences of C4-2, a tumor suppressor gene, and methods of use thereof
13 5,874,290 Full-Text Nucleotide and amino acid sequences of a D2-2 gene associated with brain tumors and methods based thereon


In addition, the USPTO currently shows the following patent applications by NWBO (admittedly, many are abandoned):

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=0&p=1&f=S&l=50&Query=an%2Fnorthwest+and+an%2Fbiotherapeutics&d=PG01


PUB. APP. NO. Title
1 20170363625 QUALITY ASSAYS FOR ANTIGEN PRESENTING CELLS
2 20140072564 THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BASED ON THE ROLE OF THE CXCR-4 GENE IN TUMORIGENESIS
3 20130273654 Generation of Dendritic Cells from Monocytic Dendritic Precursor Cells with GM-CSF in the Absence of Additional Cytokines
4 20130017600 ISOLATION AND/OR PRESERVATION OF DENDRITIC CELLS FOR PROSTATE CANCER IMMUNOTHERAPY
5 20120252034 QUALITY ASSAYS FOR ANTIGEN PRESENTING CELLS
6 20120251561 ADMINISTRATION OF DENDRITIC CELLS PARTIALLY MATURED IN VITRO FOR THE TREATMENT OF TUMORS
7 20120244620 COMPOSITIONS AND METHODS FOR INDUCING THE ACTIVATION OF IMMATURE MONOCYTIC DENDRITIC CELLS
8 20110189150 TANGENTIAL FLOW FILTRATION DEVICES AND METHODS FOR LEUKOCYTE ENRICHMENT
9 20100062003 THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BASED ON THE ROLE OF THE CXCR-4 GENE IN TUMORIGENESIS
10 20100008892 QUALITY ASSAYS FOR ANTIGEN PRESENTING CELLS
11 20080254537 Compositions and Methods for Inducing the Activation of Immature Monocytic Dendritic Cells
12 20080254064 COMPOSITIONS AND METHODS FOR PRIMING MONOCYTIC DENDRITIC CELLS AND T CELLS FOR TH-1 RESPONSE
13 20080171023 METHOD TO INCREASE CLASS I PRESENTATION OF EXOGENOUS ANTIGENS BY HUMAN DENDRITIC CELLS
14 20060234309 Quality assays for antigen presenting cells
15 20060234286 HUMAN PARIS-1 ANTIGEN AND NUCLEIC ACIDS: DIAGNOSTIC AND THERAPEUTIC USES
16 20060057120 Administration of dendritic cells partially matured in vitro for the treatment of tumors
17 20050202019 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
18 20050189297 Tangential flow filtration devices and methods for stem cell enrichment
19 20050173315 Tangential flow filtration devices and methods for leukocyte enrichment
20 20040203143 Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
21 20040197903 Method for induction of proliferation of natural killer cells by dendritic cells cultured with GM-CSF and IL-15
22 20040024188 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen